Search for Patents Expiring in Feb 2010

Glossary

Applicant	Tradename	Generic Name	NDA	Approval Date	Type	RLD	Patent Number	Product	Substance	Delist Req.	Patent Expiration	Patented / Exclusive Use
Abbott	TEVETEN HCT	eprosartan mesylate; hydrochlorothiazide	021268	Nov 1, 2001	RX	Yes	5,185,351				Feb 9, 2010	TREATMENT OF HYPERTENSION
Abbott	TEVETEN HCT	eprosartan mesylate; hydrochlorothiazide	021268	Nov 1, 2001	RX	No	5,185,351				Feb 9, 2010	TREATMENT OF HYPERTENSION
Abbott	TEVETEN	eprosartan mesylate	020738	May 27, 1999	RX	Yes	5,185,351				Feb 9, 2010	TREATMENT OF HYPERTENSION

20 30 40 50 100

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright © 2000-2010, thinkBiotech LLC.